Figure_2.tif (1.35 MB)

Expression of transgenic hIDUA in C57BL/6 mice.

Download (0 kB)
figure
posted on 21.10.2013 by Elena L. Aronovich, Bryan C. Hall, Jason B. Bell, R. Scott McIvor, Perry B. Hackett

Mice aged 12 weeks were treated with 5μg or 25μg pKT2/LSP-IDUA ± pCMV-SB100X at 5:1 and 10:1 weight ratio, respectively. Plasma IDUA activity in untreated controls (WT) was 10±4 nmol/ml/hr. The dashed double-lines indicate the therapeutic level [8]. Arrows indicate expression profiles of +SB-treated mice with gradual or incomplete loss of IDUA activity. Asterisks indicate rapid decay in CP-immunosuppressed mice. Numbers indicate mouse IDs as listed in Table 1.

History

Licence

Exports

Logo branding

Keyword(s)

Licence

Exports